North India Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 18-07-2024
- Paid Up Capital ₹ 1.50 M
as on 18-07-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.14 Cr
as on 18-07-2024
- Revenue -6.03%
(FY 2022)
- Profit 5.24%
(FY 2022)
- Ebitda -12.35%
(FY 2022)
- Net Worth 22.12%
(FY 2022)
- Total Assets 22.18%
(FY 2022)
About North India Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.14 Cr.
Anoop Bhardwaj and Avnish Bhardwaj serve as directors at the Company.
- CIN/LLPIN
U24100HR2011PTC043051
- Company No.
043051
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Karnal, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does North India Life Sciences Private Limited offer?
North India Life Sciences Private Limited offers a wide range of products and services, including Herbal Powder, Eye Care Medicines, Eye Drops, Ayurvedic Herbal Syrups & Tonics, Nervine Tonic, Liver Supplement, Ayurvedic Liver Tablets Capsules, Herbal Supplements, Herbal Sexual Health Supplement, Hair Shampoo.
Who are the key members and board of directors at North India Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avnish Bhardwaj  | Director | 25-May-2011 | Current |
| Anoop Bhardwaj | Director | 25-May-2011 | Current |
Financial Performance of North India Life Sciences.
North India Life Sciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 6.03% decrease. The company also saw a slight improvement in profitability, with a 5.24% increase in profit. The company's net worth Soared by an impressive increase of 22.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of North India Life Sciences?
In 2022, North India Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Needs Ayurveda Private LimitedActive 3 years 5 monthsAnoop Bhardwaj and Avnish Bhardwaj are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 Sep 2021 | ₹0.36 M | Open |
State Bank Of India Creation Date: 01 Jun 2020 | ₹1.50 M | Open |
State Bank Of India Creation Date: 01 Jun 2020 | ₹0.80 M | Open |
How Many Employees Work at North India Life Sciences?
Unlock and access historical data on people associated with North India Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of North India Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped North India Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
